The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis

Gastroenterology

Volumn 121, Issue 6, 2001, Pages 1407-1416

  Cooper, Harry S ^a   Everley, Lynette ^b   Chang, Wen Chi ^b   Pfeiffer, Gordon ^b   Lee, Bryan ^b   Murthy, Sreekant ^c   Clapper, Margie L ^b  

^a Division of Medical Science   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DEXTRAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CECUM; COLON MUCOSA; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASIA; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; LARGE INTESTINE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0035206705     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2001.29609     Document Type: Article

References (42)

1. Colonoscopic surveillance of longstanding total ulcerative colitis - A 15 year follow-up study
2. Consideration of surveillance, dysplasia and carcinoma of the colon in the management of ulcerative colitis in Crohn's disease
3. Twenty years colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplasia and malignant transformation
4. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. Critical review
5. Factors effecting the outcome of endoscopic surveillance for cancer in ulcerative colitis
6. Pre-cancer and cancer in extensive ulcerative colitis: Findings among 401 patients in over 22 years
7. Surveillance for colonic carcinoma in ulcerative colitis
8. Ulcerative colitis in colorectal cancer
9. A germline substitution in the human MSH2 gene is associated with high grade dysplasia and cancer in ulcerative colitis
10. Use of a microsatellite marker in predicting dysplasia in ulcerative colitis
11. Familial predisposition for colorectal cancer in chronic ulcerative colitis: A case-control study
12. Colorectal cancer prevention in ulcerative colitis: A case controlled study
13. Family history as a risk factor for colorectal cancer in inflammatory bowel disease
14. Family history as a risk factor for ulcerative colitis-associated colon cancer in cotton top tamarin
15. A genetic model for colorectal tumorigenesis
16. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms
17. Molecular genetic profiles of colitis-associated neoplasms
18. Comparison of genetic alterations in colonic adenoma and ulcerative colitis-associated dysplasia and carcinoma
19. Loss of heterozygosity of the von Hippel Lindau gene locus in polypoid dysplasia but not flat dysplasia in ulcerative colitis or sporadic adenomas
20. Common occurrence of APC and K-ras gene mutations in the spectrum of colitis associated neoplasias
21. Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization
22. Loss of heterozygosity affecting the p53, Rb, and MCC/APC tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis
23. Inactivation of both APC alleles in human and mouse tumors
24. Loss of APC in intestinal adenomas from MIN mice
25. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorogenesis
26. PCR based assay for the murine multiple intestinal neoplasia (MIA) mutation
27. Clinicopathologic study of dextran sulfate sodium experimental murine colitis
28. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis associated neoplasia in the human: Study of histopathology, beta-catenin and p53 expression and the role of inflammation
29. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical application
30. A germline hMSH2 alteration is unrelated to colonic microsatellite instability in patients with ulcerative colitis
31. Promotion of colorectal neoplasia in experimental murine ulcerative colitis
32. Enhancing effect of dextran sulfate sodium on colorectal carcinogenesis by 1, 2-dimethylhydrazine in rats
33. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli min mouse model with aspirin
34. Min mouse model by the non-steroidal anti-inflammatory piroxicam
35. Short chain fructo-oligosaccharides reduce the occurrence of colon tumors and develop gut-associated lymphoid tissue in Min mice
36. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice
37. P53 and B-catenin expression in chronic ulcerative colitis-associated polyp dysplasia and sporadic adenomas: An immunohistochemical study
38. P53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma
39. Genetic alterations in chronic ulcerative colitis-associated adenoma-like Dalms are similar to non-colitis sporadic adenomas
40. Genomic instability is an early event during the progression pathway of ulcerative colitis related neoplasia
41. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
42. Genetic analysis of susceptibility of dextran sulfate sodium-induced colitis in mice